Rhodium(III) and iridium(III) complexes as anticancer agents
Abstract
Until recently, Rh(III) and particularly Ir(III) complexes were generally considered as being unlikely candidates for anticancer agents owing to the typical kinetic inertness of their transition metal centres. Systematic studies on the cellular impact of a range of octahedral Rh(III) complexes containing polypyridyl and other aromatic chelates have now, however, demonstrated that high cytotoxicity in cancer cells and in certain cases promising...
Paper Details
Title
Rhodium(III) and iridium(III) complexes as anticancer agents
Published Date
Dec 1, 2012
Journal
Volume
393
Pages
84 - 102
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History